Oxidative Stress, Glutamate, and Neurodegenerative Disorders
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
There is an increasing amount of experimental evidence that oxidative stress is a causal, or at least an ancillary, factor in the neuropathology of several adult neurodegenerative disorders, as well as in stroke, trauma, and seizures. At the same time, excessive or persistent activation of glutamate-gated ion channels may cause neuronal degeneration in these same conditions. Glutamate and related acidic amino acids are thought to be the major excitatory neurotransmitters in brain and may be utilized by 40 percent of the synapses. Thus, two broad mechanisms—oxidative stress and excessive activation of glutamate receptors—are converging and represent sequential as well as interacting processes that provide a final common pathway for cell vulnerability in the brain. The broad distribution in brain of the processes regulating oxidative stress and mediating glutamatergic neurotransmission may explain the wide range of disorders in which both have been implicated. Yet differential expression of components of the processes in particular neuronal systems may account for selective neurodegeneration in certain disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and inflammation are early events of neurodegenerative diseases [920,944-957]”
In the citing paper
“lipid peroxidation could be a major feature of ferroptosis in AD”
In the citing paper
“the brain contains the high levels of polyunsaturated fatty acids (PUFAs) in its membrane rich architecture”
In the citing paper
“The pathophysiology of depression is multifactorial and includes changes in brain monoaminergic transmission (e.g., 5-HT, NE, DA), abnormalities in neurotransmitter receptors function (e.g., AC-cAMP pathway), reduced neurotrophic factors (e.g., BDNF), dysregulation of HPA axis (cortisol), increased proinflammatory cytokines (e.g., IL-6, TNF-α, NF-κB), increased NO (e.g., L-arginine-NO-cGMP pathway”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [45]
Citations
Cites
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,859
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Vitamin E Consumption and the Risk of Coronary Disease in Women
Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B., & Willett, W. C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282003 · Cited by 2,103
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Research works printed but not linked: 8
- CHAN, P.H., REDUCED NEUROTOXICITY IN TRANSGENIC MICE OVEREXPRESSING HUMAN COPPER-ZINC SUPEROXIDE-DISMUTASE, STROKE 21: 80 (1990).
- CHOI, D.W., METHODS FOR ANTAGONIZING GLUTAMATE NEUROTOXICITY, CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 2: 105 (1990).
- DICHTER, M, EPILEPSIA 30: S3 (1989).
- HALLIWELL, B, ACTA NEUROLOGICA SCANDINAVICA 80 126: 23 (1989).
- JENNER, P, OXIDATIVE STRESS AS A CAUSE OF PARKINSONS-DISEASE, ACTA NEUROLOGICA SCANDINAVICA 84: 6 (1991).
- Olney, J. W., Kainic Acid as a Tool in Neurobiology: 95 (1978).
- SIESJO, B. K., CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS 1: 165 (1989).
- TELLEZ-NAGEL, I, ADVANCES IN NEUROLOGY 1: 387 (1973).
Cited by
Items 701–800 of 1,019
Kim, S. R., Lee, M. K., Koo, K. A., Kim, S. H., Sung, S. H., Lee, N. G., Markelonis, G. J., Oh, T. H., Yang, J., & Kim, Y. C. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20089 · Cited by 111
“However, glutamate also causes neuronal cell loss (Choi, 1988; Coyle and Puttfarcken, 1993) by two distinct forms of response, acute and delayed (Choi, 1985, 1987).”
BackgroundDing, W., Shen, H., & Ong, C. N. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6453 · Cited by 111
Reiter, R. J., Cabrera, J., Sainz, R. M., Mayo, J. C., Manchester, L. C., & Tan, D. X. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08028.x · Cited by 116
“17,18 Singlet oxygen ((1)O2) is formed by the addition of energy to ground state oxygen (reaction [5]).”
BackgroundHerson, P. S., Lee, K., Pinnock, R. D., Hughes, J., & Ashford, M. L. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.833 · Cited by 111
Wang, J., Pang, T., Hafko, R., Benický, J., Sánchez-Lemus, E., & Saavedra, J. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.022 · Cited by 118
“2010; Coyle and Puttfarcken, 1993; Lau and Tymianski, 2010; Tian et al., 2008).”
Chapter 21 Glutamate toxicity in chronic neurodegenerative disease
Lancelot, E., & Beal, M. F. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60446-x · Cited by 122
Luo, J., & Shi, R. (2003) · Neurochemistry International · doi:10.1016/j.neuint.2003.09.006 · Cited by 116
“…fatty acids in the plasma membranes, occurs in traumatic central nervous system injuries (Hall, 1996; Lewen et al., 2000; Povlishock and Kontos, 1992) and in neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases (Coyle and Puttfarcken, 1993; Farooqui and Horrocks, 1998).”
BackgroundChromium(VI) induces oxidative stress in the mouse brain
Travacio, M., Polo, J. M., & Llesuy, S. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00254-7 · Cited by 118
Down Syndrome: Advances in Molecular Biology and the Neurosciences
CAPONE, G. T. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00007 · Cited by 110
Acrolein-induced cell death in PC12 cells: Role of mitochondria-mediated oxidative stress
Luo, J., Robinson, J. P., & Shi, R. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.07.002 · Cited by 114
“Oxidative stress has been implicated in various neurodegenerative conditions and disorders including ischemiareperfusion, traumatic injury, Parkinson’s disease (PD) and Alzheimer’s disease (AD) (Coyle and Puttfarcken, 1993).”
Liu, H., Cao, Y., Basbaum, A. I., Mazarati, A. M., Sankar, R., & Wasterlain, C. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12096 · Cited by 110
Giusti, P., Gusella, M., Lipartiti, M., Milani, D., Zhu, W., Vicini, S., & Manev, H. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90005-5 · Cited by 114
The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective
Brinton, R. D., Chen, S., Montoya, M., Hsieh, D., Minaya, J., Kim, J., & Chu, H. P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00109-3 · Cited by 110
“over, glutamate-induced excitotoxicity has been proposed to be one of the contributing factors to the neurodegenerative characteristic of Alzheimer’s disease and other neuropathological states [15,30].”
BackgroundAbnormal calcium homeostasis and mitochondrial polarization in a human encephalomyopathy.
Moudy, A. M., Handran, S. D., Goldberg, M. P., Ruffin, N., Karl, I., Kranz-Eble, P., DeVivo, D. C., & Rothman, S. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.729 · Cited by 109
Ji, H., Hu, J., Wang, Y., Chen, X., Zhou, R., & Chen, N. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.038 · Cited by 111
“Previous studies have revealed that oxidative injury plays a key role in the pathogenesis of numerous neurodegenerative diseases including stroke, Alzheimer's disease, and vascular dementia, etc. (Chong et al., 2005; Coyle and Puttfarcken, 1993; Markesbery, 1997).”
BackgroundHatziagapiou, K., Kakouri, E., Lambrou, G. Ι., Bethanis, K., & Tarantilis, P. Α. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180321095705 · Cited by 113
Glutamate stimulates neurotrophin expression in cultured Müller cells
Taylor, S. C., Srinivasan, B., Wordinger, R. J., & Roque, R. S. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00030-5 · Cited by 109
Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108
“Our results strongly support the notion that oxidative damage is highly involved in the etiopathogenesis of PD [44,45].”
Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration
Maier, O., Böhm, J., Dahm, M., Brück, S., Beyer, C., & Johann, S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.03.008 · Cited by 108
Chu, Z., Liu, Y., & Jin, W. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.04.036 · Cited by 108
“Abnormal glutamate levels are mainly due to the occurrence of cerebral ischemia, Parkinson's disease and epilepsy (Coyle and Puttfarcken, 1993; Jenkins et al., 2016).”
BackgroundNeurotrophic factors in Huntington's disease
Alberch, J., Pérez‐Navarro, E., & Canals, J. M. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46014-7 · Cited by 119
Kraft, A. D., Lee, J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04019.x · Cited by 107
“In the hippocampus itself, the most robustly stained area is the CA3 subfield, a region of pyramidal neurons interspersed with inhibitory neurons and supportive astrocytes (Figs 1c and g). Importantly, the CA3 region has the highest abundance of kainate receptors, the activation of which is known to elevate the concen…”
BackgroundOxidative stress – assassin behind the ischemic stroke
Pradeep, H., Diya, J. B., Shashikumar, S., & Rajanikant, G. K. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.30522 · Cited by 102
“As the brain possesses low levels of antioxidants, neurons are re latively vulnerable to oxidative stress than any other cells of the body [21].”
BackgroundAlzheimer’ s disease, oxidative stress and gammahydroxybutyrate
Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 118
Microstructure and Network Organization of the Microvasculature in the Human Macula
Yu, P. K., Balaratnasingam, C., Cringle, S. J., McAllister, I. L., Provis, J. M., & Yu, D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5415 · Cited by 114
Sheng, G., Zhang, J., Pu, X., Ma, J., & Li, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02240-9 · Cited by 116
Balu, M., Sangeetha, P., Murali, G., & Panneerselvam, C. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.06.001 · Cited by 111
“Free radical formation is linked to normal cellular processes including cell metabolism, mitochondrial respiration, lipoxygenase, and cyclooxygenase activity (Coyle and Puttfarcken, 1993), which may increase in the maturing brain (Freeman and Crapo, 1982).”
BackgroundRecent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems
Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., & Pinnen, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/240146 · Cited by 105
Ahlemeyer, B., Möwes, A. K., & Krieglstein, J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00903-0 · Cited by 112
Meyer, J., Huberth, A., Ortega, G., Syagailo, Y. V., Jatzke, S., Mößner, R., Strom, T. M., Ulzheimer-Teuber, I., Stöber, G., Schmitt, A. G., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000869 · Cited by 108
Erratum: correction: Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-Ĺ. (2001) · Nature · doi:10.1038/35054111 · Cited by 109
Hatami, T., Emami, S. A., Miraghaee, S., & Mojarrab, M. (2014) · PubMed Central · Cited by 181
Santamaría, A., Salvatierra‐Sánchez, R., Vázquez‐Román, B., Santiago‐López, D., Villeda‐Hernández, J., Galván‐Arzate, S., Jiménez‐Capdeville, M. E., & Ali, S. F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01857.x · Cited by 105
“Excessive activation of glutamate receptors in the mammalian brain represents a cytotoxic mechanism that is poten- tially involved in neurodegenerative processes (Coyle and Puttfarcken 1993).”
BackgroundOr, T. C. T., Yang, C. L.-H., Law, A. H. Y., Li, J., & Lau, A. S. Y. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.002 · Cited by 107
Methylmalonate toxicity in primary neuronal cultures
McLaughlin, B. A., Nelson, D., Silver, I. A., Erecinska, M., & Chesselet, M.-F. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00594-0 · Cited by 108
Vandenberg, R. J., Mitrovic, A. D., Chebib, M., Balcar, V. J., & Johnston, G. A. R. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.809 · Cited by 107
Bar-Peled, O., Korkotian, E., Segal, M., & Groner, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8530 · Cited by 107
Metabolomics studies in brain tissue: A review
González-Riaño, C., García, A., & Barbas, C. (2016) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2016.07.008 · Cited by 114
Status of essential elements in autism spectrum disorder: systematic review and meta-analysis
Saghazadeh, A., Ahangari, N., Hendi, K., Saleh, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0015 · Cited by 111
Satoh, T., & Lipton, S. A. (2017) · F1000Research · doi:10.12688/f1000research.12111.1 · Cited by 106
Cognitive dysfunctions in individuals with diabetes mellitus
Kim, H.-G. (2019) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2019.00255 · Cited by 116
“Another mechanism is glutamate accumulation in the context of hyperglycemia and ischemia [49,50].”
BackgroundLeipnitz, G., Schumacher, C., Dalcin, K. B., Scussiato, K., Solano, A. F., Funchal, C., Dutra‐Filho, C. S., Wyse, Â. T. D. S., Wannmacher, C. M. D., Latini, A., et al. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.017 · Cited by 106
“enzymes catalase and glutathione peroxidase have been demonstrated in patients affected by these disorders (Olanow, 1993; Coyle and Puttfarcken, 1993; Perry et al., 2003).”
BackgroundCopin, J., Gasche, Y., & Chan, P. H. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00280-x · Cited by 119
Zhu, H., & Liu, G.-Q. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.02.027 · Cited by 106
Weecharangsan, W., Opanasopit, P., Sukma, M., Ngawhirunpat, T., Sotanaphun, U., & Siripong, P. (2006) · Medical Principles and Practice · doi:10.1159/000092991 · Cited by 146
The coordination chemistry of aluminium in neurodegenerative disease
Exley, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.02.020 · Cited by 114
Mason, R. P., Leeds, P. R., Jacob, R. F., Hough, C. J., Zhang, K., Mason, P. E., & Chuang, D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721448.x · Cited by 110
Xu, H., Wang, J., Li, M., Liu, Y., Chen, T., & Jia, A. (2014) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.11.020 · Cited by 107
Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicity
Brassai, A., Suvanjeiev, R.-G., Bán, E.-G., & Lakatos, M. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.12.007 · Cited by 112
Rodrigues, R., Petersen, R. B., & Perry, G. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0074-5 · Cited by 99
“…this question to be exceptionally significant and explanatory, since oxidative stress and hippocampal-cortical atrophy are currently considered (Coyle and Puttfarcken 1993; de Leon et al. 1997; Jellinger 2007; de Leon et al. 1989; 936 Cell Mol Neurobiol (2014) 34:925–949 Lupien et al. 1998) to…”
InfluentialHussein, R. M., Mohamed, W. R., & Omar, H. A. (2018) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2018.08.008 · Cited by 101
Protective effect of Nardostachys jatamansi in rat cerebral ischemia
Salim, S., Ahmad, M., Zafar, K. S., Ahmad, A. S., & Islam, F. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01030-4 · Cited by 105
Lee, H.-H., Yang, L.-L., Wang, C.-C., Hu, S.-Y., Chang, S., & Lee, Y. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03197-4 · Cited by 108
Deficiency of the Mre11 DNA repair complex in Alzheimer's disease brains
Jacobsen, E. A., Beach, T. G., Shen, Y., Li, R., & Chang, Y. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.05.023 · Cited by 110
Nguemeni, C., Delplanque, B., Rovère, C., Simon-Rousseau, N., Gandin, C., Agnani, G., Nahon, J., Heurteaux, C., & Blondeau, N. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.007 · Cited by 108
Tardive Dyskinesia: Possible Involvement of Free Radicals and Treatment With Vitamin E
Elkashef, A. M., & Wyatt, R. J. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033414 · Cited by 115
Numakawa, Y., Numakawa, T., Matsumoto, T., Yagasaki, Y., Kumamaru, E., Kunugi, H., Taguchi, T., & Niki, E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03827.x · Cited by 112
Arachidonic Acid and Leukotriene C4: Role in Transient Cerebral Ischemia of Gerbils
Rao, A. M., Hatcher, J. F., Kindy, M. S., & Dempsey, R. J. (1999) · Neurochemical Research · doi:10.1023/a:1020916905312 · Cited by 105
“oxygen radical induced neuronal death (4) in ischemia”
BackgroundKainic Acid‐Induced Apoptosis in Rat Striatum Is Associated with Nuclear Factor‐κB Activation
Nakai, M., Qin, Z., Chen, J., Wang, Y., & Chase, T. N. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740647.x · Cited by 104
Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment
Faherty, C. J., Xanthoudakis, S., & Smeyne, R. J. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00143-6 · Cited by 103
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Doty, K. R., Guillot-Sestier, M.-V., & Town, T. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.008 · Cited by 104
“This phenotype is characterized by ROS production, inflammasome activation and secretion of IL-1β, COX1/2 mediated prostaglandins, activation of P2X7 and TLRs by DAMPs, and immune modulation by ApoE ε4 in carriers.”
InfluentialGeisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
Lezoualc'h, F., Sparapani, M., & Behl, C. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00530.x · Cited by 105
Chemical constituents and medicinal properties of Allium species
Bastaki, S. M. A., Ojha, S. K., Kalász, H., & Adeghate, E. A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04213-2 · Cited by 109
Ammonia Neurotoxicity: Role of the Mitochondrial Permeability Transition
Rao, K. V. R., Jayakumar, A. R., & Norenberg, M. D. (2003) · Metabolic Brain Disease · doi:10.1023/a:1023858902184 · Cited by 110
“However, it is known that increased intracellular levels of Ca 2+ contribute to free-radical production (Coyle and Puttfarcken, 1993; Halliwell, 1992).”
BackgroundPotentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site
Shim, S. S., Hammonds, M. D., & Kee, B. S. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0757-8 · Cited by 108
“The NMDAR hypofunction theory of schizophrenia proposes that a diminished function of NMDARs can produce sublethal and lethal neuronal injury including apoptosis-like neuronal death in schizophrenic patients [13, 23, 88].”
BackgroundMaher, P. A., & Hanneken, A. M. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0883 · Cited by 115
Nishio, E., & Watanabe, Y. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701171 · Cited by 101
Reichelt, W., Stabel, J., Pannicke, T., Weichert, H., & Heinemann, U. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00509-x · Cited by 103
Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA)
Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Bêcher, M. W., & Aylward, E. (1997) · Medicine · doi:10.1097/00005792-199709000-00001 · Cited by 110
Mutants of Saccharomyces cerevisiae sensitive to oxidative and osmotic stress
Krems, B., Charizanis, C., & Entian, K. (1995) · Current Genetics · doi:10.1007/bf00311211 · Cited by 103
Parihar, M. S., & Hemnani, T. (2003) · Journal of Biosciences · doi:10.1007/bf02970142 · Cited by 102
“| Vol. 28 | No. 1 | February 2003 M S Parihar and Taruna Hemnani 126 within the nervous system and appears to be mediated by reactive oxygen species (Beal 1997; Coyle and Puttfarcken 1993; Law et al 2001).”
BackgroundMartinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143504 · Cited by 112
“The excitatory glutamate, which could act toxically at higher concentrations, is thought to be one of the major contributors in oxidative stress development [38].”
Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington’s disease
Hong, C., Seo, H., Kwak, M., Jeon, J., Jang, J., Jeong, E. M., Myeong, J., Hwang, Y. J., Ha, K., Kang, M. J., et al. (2015) · Brain · doi:10.1093/brain/awv188 · Cited by 102
“Furthermore, glutamate toxicity is a major contributor to pathological neuron cell death and is mediated by reactive oxygen species and GSH loss (Coyle and Puttfarcken, 1993; Herrera et al., 2007).”
BackgroundBuck, K., Voehringer, P., & Ferger, B. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2009.05.018 · Cited by 102
Emerging roles of thioredoxin cycle enzymes in the central nervous system
Patenaude, A., Murthy, M. R. V., & Mirault, M.-É. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4541-5 · Cited by 112
Heo, H. J., Kim, D., Choi, S. J., Shin, D. H., & Lee, C. Y. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf049953x · Cited by 113
Aliev, G., Palacios, H. H., Walrafen, B., Lipsitt, A. E., Obrenovich, M. E., & Morales, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.015 · Cited by 109
Multiple Antioxidants in the Prevention and Treatment of Parkinson’s Disease
Prasad, K. N., Cole, W. C., & Kumar, B. (1999) · Journal of the American College of Nutrition · doi:10.1080/07315724.1999.10718878 · Cited by 114
Arany, I., Megyesi, J. K., Kaneto, H., Tanaka, S., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00500.x · Cited by 102
“Damage to cells during IsR injury is associated with the formation of reactive oxygen species (ROS) and free radical”
BackgroundMartinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499447 · Cited by 105
Protection of Apigenin against Kainate-Induced Excitotoxicity by Anti-oxidative Effects
Han, J., Ahn, S., Kim, C.-S., Yoo, S.-K., Kim, S., Kim, H., Hong, J. T., & Oh, K. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b110686 · Cited by 106
Melatonin maintains glutathione homeostasis in kainic acid‐exposed rat brain tissues
Floreani, M., Skaper, S. D., Facci, L., Lipartiti, M., & Giusti, P. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.14.9409550 · Cited by 102
Neutralization of TRAIL death pathway protects human neuronal cell line from β-amyloid toxicity
Cantarella, G., Uberti, D. L., Carsana, T., Lombardo, G. A. G., Bernardini, R., & Memo, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401143 · Cited by 106
Ko, S., Lin, Y.-P., Lin, Y.-S., & Chang, S.-S. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.005 · Cited by 104
Peroxynitrite Induces Tyrosine Nitration and Modulates Tyrosine Phosphorylation of Synaptic Proteins
Stasi, A. M. M. D., Mallozzi, C., Macchia, G., Petrucci, T. C., & Minetti, M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730727.x · Cited by 102
“Neuronal damage by oxidative stress has long been hypothesized as a critical mechanism of cellular damage in aging (Berlett and Stadtman, 1997) and neurodegenerative diseases (Coyle and Puttfarcken, 1993; Good et al., 1996).”
BackgroundAcid sensing ion channels - novel therapeutic targets for ischemic brain injury
Xiong, Z., Chu, X.-P., & Simon, R. P. (2006) · Frontiers in bioscience · doi:10.2741/2154 · Cited by 109
Potent effects of dioscin against obesity in mice
Liu, M., Xu, L., Yin, L., Qi, Y., Xu, Y., Han, X., Zhao, Y., Sun, H., Yao, J., Lin, Y., et al. (2015) · Scientific Reports · doi:10.1038/srep07973 · Cited by 101
Fu, X., Zhang, J., Guo, L., Xu, Y., Sun, L., Wang, S., Feng, Y., Gou, L., Zhang, L., & Liu, Y. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.09.005 · Cited by 105
Kiningham, K. K., Oberley, T. D., Lin, S. ‐., Mattingly, C. A., & Clair, D. K. S. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.12.1601 · Cited by 97
“cell death pathways upon treatment with a variety of agents including TNF-a (12), ceramide (13), glutamate (14), amyloid b-peptide (15, 16), alkaline conditions (17), and nerve growth factor withdrawal (18, 19).”
BackgroundOxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons
Cheng, Y., & Sun, A. Y. (1994) · Neurochemical Research · doi:10.1007/bf00969006 · Cited by 103
“In fact, a large amount of evidence indicates that various kinds of brain damage related to excitotoxic insults, such as epilepsy and hypoxia-ischemia, are due to the generation of excessive amounts of free radicals ( 28 ).”
BackgroundZindo, F. T., Joubert, J., & Malan, S. F. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.12 · Cited by 109
Ischemia and lesion induced imbalances in cortical function
Luhmann, H. J. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00042-9 · Cited by 104
Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats
Liu, C., Wu, J., Gu, J. F., Xiong, Z., Wang, F., Wang, J., Wang, W., & Chen, J. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.11.005 · Cited by 101
Ledo, A., Barbosa, R. M., Gerhardt, G. A., Cadenas, E., & Laranjinha, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503624102 · Cited by 97
Petersén, Å., Castilho, R. F., Hansson, O., Wieloch, T. W., & Brundin, P. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02320-3 · Cited by 103
Neuroprotective effects of α-lipoic acid and its positively charged amide analogue
Tirosh, O., Sen, C. K., Roy, S., Kobayashi, M. S., & Packer, L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00014-3 · Cited by 104
Chhunchha, B., Fatma, N., Kubo, E., Rai, P., Singh, S. P., & Singh, D. P. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00345.2012 · Cited by 102
“In addition, these cells have only a feeble antioxidant defense, due to their low levels of endogenous antioxidant enzymes (20).”
BackgroundProtection of methamphetamine nigrostriatal toxicity by dietary selenium
Kim, H., Jhoo, W., Choi, D., Im, D., Shin, E., Suh, J.-H., Floyd, R. A., & Bing, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02122-8 · Cited by 98
Saleem, S., Ahmad, M., Ahmad, A. S., Yousuf, S., Ansari, M. A., Khan, M. B., Ishrat, T., & Islam, F. (2006) · Journal of Medicinal Food · doi:10.1089/jmf.2006.9.246 · Cited by 115
“…extracellular fluid, 29,30 which can induces excessive activation of N -methyl- D - aspartate or 2-amino-3-hydroxy-5-isoxazole propionate/ kainate receptors resulting in accumulation of intracellular fluid and sodium and calcium ions, 31 which induced generation of lipid peroxide and free radicals.”
Metadata
- Authors
- Coyle, J. T., & Puttfarcken, P.
- Affiliations
- Harvard University (US)
- ORCID
- Coyle, Joseph T.
- Venue
- Science
- Published
- 1993-10-29
- Volume
- 262
- Issue
- 5134
- Pages
- 689-695
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2016293448
- Cited by
- 3,762
- References
- 104
- Citations by year
- 2026: 22 · 2025: 33 · 2024: 56 · 2023: 58 · 2022: 51 · 2021: 66 · 2020: 74 · 2019: 83 · 2018: 89 · 2017: 104 · 2016: 105 · 2015: 99 · 2014: 158 · 2013: 126 · 2012: 137
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, glutamate, neurodegenerative diseases, glutamate receptors, excitotoxicity, glutamatergic neurotransmission, neurodegeneration, stroke, traumatic brain injury, seizures, selective neurodegeneration, acidic amino acids
- MeSH terms
- Animals, Brain, Glutamates, Humans, Nervous System Diseases, Reactive Oxygen Species, Receptors, Glutamate, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.